Merck and Mersana Therapeutics to co-develop new immunostimulatory ADCs
Merck has announced a collaboration with US-based Mersana Therapeutics to discover new antibody-drug conjugates (ADCs) by leveraging the latter’s proprietary Immunosynthen STING-agonist ADC platform. The ... Read More
AstraZeneca to acquire cell therapy company Neogene Therapeutics
AstraZeneca will acquire Neogene Therapeutics, a US-based clinical-stage biotechnology company, for a total consideration of up to $320 million, bringing next-generation transformative cell therapies for ... Read More
Lupin subsidiary MedQuímica buys rights to nine drugs from Bausch Health
Lupin Limited said that MedQuímica Indústria Farmacêutica, its 100% subsidiary in Brazil, has agreed to acquire all rights to nine drugs from Bausch Health Companies’ ... Read More
FDA approves Janssen’s TECVAYLI for multiple myeloma treatment
The Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced the US Food and Drug Administration's approval of its first bispecific T-cell engager antibody, ... Read More
Alembic Pharmaceuticals gets FDA final approval for Paclitaxel Injection USP
Alembic Pharmaceuticals Limited has secured final approval for its abbreviated new drug application (ANDA) for Paclitaxel Injection USP, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 ... Read More
Clinical-stage pharma firms Ayala Pharmaceuticals, Advaxis sign merger deal
Ayala Pharmaceuticals, a Nasdaq-listed clinical-stage oncology company, has entered into a merger deal with New Jersey-based biotech company Advaxis. Based in Delaware, Ayala Pharmaceuticals is ... Read More
LG Chem to acquire US biotech company Aveo Oncology for $566m
LG Chem acquisition of Aveo Oncology : South Korea’s LG Chem has entered into a definitive agreement to acquire Aveo Oncology, a US-based biotech company, ... Read More
Gilead gets Trodelvy FDA priority review for pre-treated HR+/HER2- metastatic breast cancer
Gilead Sciences said that Trodelvy (sacituzumab govitecan-hziy) has been granted priority review from the US Food and Drug Administration (FDA) for the treatment of another ... Read More
Aster DM Healthcare partners AP’s Narayanadri Hospital to expand India presence
Aster DM Healthcare has partnered with Andhra Pradesh’s Narayanadri Hospital to expand its hospital operations management services in India. The partnership is part of the ... Read More
Aura Biosciences begins dosing in belzupacap sarotalocan phase 1 trial in NMIBC
Aura Biosciences said that it has dosed the first patient in a phase 1 clinical trial of its first virus-like drug conjugate (VDC) — belzupacap ... Read More